|
|
Blood, 1 May 2007, Vol. 109, No. 9, pp. 3865-3872.
Prepublished online as a Blood First Edition Paper on January 5, 2007; DOI 10.1182/blood-2006-09-046748.
Previous Article | Next Article 
Submitted September 12, 2006
Accepted December 14, 2006
Vitamin A potentiates CpG-mediated memory B cell proliferation and differentiation: Involvement of early activation of p38MAPK
Aase Ertesvag, Hans-Christian Aasheim, Soheil Naderi, and Heidi Kiil Blomhoff*
Dept of Biochemistry, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Dept of Immunology, Rikshospitalet-Radiumhospitalet, Oslo, Norway
* Corresponding author; email: h.k.blomhoff{at}basalmed.uio.no.
Foreign CpG-DNA from viruses and bacteria can activate memory B cells through binding to toll-like receptor 9, and this pathway has been hypothesized to be involved in the continuous activation of memory B cells ensuring life-long humoral immunity. In this study we demonstrate that retinoic acid (RA) is a potent co-activator of this pathway in human B cells. RA enhanced the CpG-mediated proliferation of CD27+ memory B cells, and the proliferative response was accompanied by increased immunoglobulin (Ig) secretion indicative of plasma cell formation. The RA-induced proliferation was preceded by enhanced expression of cyclin D3, and both the expression of cyclin D3 and the induced Ig secretion was found to be dependent on IL-10. Importantly, RA increased the CpG-induced phosphorylation of ERK1/2, p38MAPK and I B as early as 30 minutes after stimulation. By using specific inhibitors, all the RA-mediated events, including proliferation, cyclin D3 expression, IL-10 secretion, and Ig secretion were shown to be dependent on p38MAPK. Hence, we propose that RA can strengthen humoral immunity by promoting CpG-mediated stimulation of CD27+ B cells via activation of p38MAPK resulting in increased proliferation and differentiation to Ig-secreting plasma cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. M. Garcia-Bates, C. J. Baglole, M. P. Bernard, T. I. Murant, P. J. Simpson-Haidaris, and R. P. Phipps
Peroxisome Proliferator-Activated Receptor {gamma} Ligands Enhance Human B Cell Antibody Production and Differentiation
J. Immunol.,
December 1, 2009;
183(11):
6903 - 6912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ma and A. C. Ross
Toll-Like Receptor 3 Ligand and Retinoic Acid Enhance Germinal Center Formation and Increase the Tetanus Toxoid Vaccine Response
Clin. Vaccine Immunol.,
October 1, 2009;
16(10):
1476 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Capolunghi, S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al.
CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies
J. Immunol.,
January 15, 2008;
180(2):
800 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|